Literature DB >> 26908544

Research involving pediatric stem cell donors: A way forward.

David Wendler1, Nirali N Shah2, Michael A Pulsipher3, Terry Fry2, Christine Grady4.   

Abstract

The most suitable donor for younger patients who undergo hematopoietic stem cell transplantation in the research setting is frequently a minor sibling. These cases raise the question of whether minors who serve as stem cell donors for research subjects should be regarded as research subjects themselves. Regarding pediatric donors as research subjects ensures that an Institutional Review Boards reviews their involvement and determines whether it is appropriate. Yet, Institutional Review Boards must follow the US regulations for pediatric research, which were designed for patients and healthy volunteers, not for healthy donors. As a result, regarding pediatric donors as research subjects also can pose unnecessary obstacles to appropriate and potentially life-saving research. This article considers a new way to address this dilemma. The federal research regulations allow for waiver of some or all of the included requirements when they are unnecessary for a study or a class of studies. We argue that this option offers a way to ensure that the involvement of pediatric donors receives sufficient review and approval without inadvertently undermining valuable and potentially life-saving research.
© The Author(s) 2016.

Entities:  

Keywords:  Transplantation; donor; pediatric; regulations

Mesh:

Year:  2016        PMID: 26908544      PMCID: PMC4965294          DOI: 10.1177/1740774515627156

Source DB:  PubMed          Journal:  Clin Trials        ISSN: 1740-7745            Impact factor:   2.486


  9 in total

Review 1.  Defining and describing benefit appropriately in clinical trials.

Authors:  N M King
Journal:  J Law Med Ethics       Date:  2000       Impact factor: 1.718

2.  Interpretation of the subjects' condition requirement: a legal perspective.

Authors:  Seema Shah; David Wendler
Journal:  J Law Med Ethics       Date:  2010       Impact factor: 1.718

3.  When can children with conditions be in no-benefit, higher-hazard pediatric studies?

Authors:  Loretta M Kopelman
Journal:  Am J Bioeth       Date:  2007-03       Impact factor: 11.229

Review 4.  Weighing the risks of G-CSF administration, leukopheresis, and standard marrow harvest: ethical and safety considerations for normal pediatric hematopoietic cell donors.

Authors:  Michael A Pulsipher; Arnon Nagler; Robert Iannone; Robert M Nelson
Journal:  Pediatr Blood Cancer       Date:  2006-04       Impact factor: 3.167

5.  Children as hematopoietic cell donors in research: when is it approvable?

Authors:  N N Shah; A S Wayne; C Grady; T Fry; D Wendler
Journal:  Bone Marrow Transplant       Date:  2014-10-20       Impact factor: 5.483

6.  Unrelated hematopoietic stem cell donors as research subjects.

Authors:  R J King; D L Confer; H T Greinix; J Halter; M Horowitz; A H Schmidt; P Costeas; B Shaw; T Egeland
Journal:  Bone Marrow Transplant       Date:  2010-03-01       Impact factor: 5.483

7.  Views of adolescents and parents on pediatric research without the potential for clinical benefit.

Authors:  David Wendler; Emily Abdoler; Lori Wiener; Christine Grady
Journal:  Pediatrics       Date:  2012-09-10       Impact factor: 7.124

8.  Rethinking risk in pediatric research.

Authors:  Kathleen Cranley Glass; Ariella Binik
Journal:  J Law Med Ethics       Date:  2008       Impact factor: 1.718

9.  Children as hematopoietic stem cell donors.

Authors: 
Journal:  Pediatrics       Date:  2010-01-25       Impact factor: 7.124

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.